The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation.
Metafuni E, Cavattoni IM, Lamparelli T, Raiola AM, Ghiso A, Galaverna F, Gualandi F, Di Grazia C, Dominietto A, Varaldo R, Signori A, Chiusolo P, Sora' F, Giammarco S, Laurenti L, Sica S, Angelucci E, Bacigalupo A.
Metafuni E, et al. Among authors: laurenti l.
Blood Adv. 2022 Apr 12;6(7):2309-2318. doi: 10.1182/bloodadvances.2021005675.
Blood Adv. 2022.
PMID: 34920451
Free PMC article.
Clinical Trial.